The PSNC has said it is concerned that some general practice teams are referring patients to pharmacies “informally”.

Pharmacies can deliver flu vaccines using the DHSC's centrally procured stock from tomorrow.

Plans are underway to look at how more pharmacies can be involved in the Covid-19 vaccination programme, the PSNC has said.

Government under intense criticism for failing to deploy England’s community pharmacy network to help deliver Covid vaccinations on a wide scale.

PSNC and DHSC agree mechansim for PPE reimbursement claims

Changes will provide additional capacity for contractors to implement the Discharge Medicines Service in February, says PSNC

Regulations guidance has been published to support pharmacy contractors in providing the service

Any PPE purchased up to 31 December will be covered by reimbursement mechanism

The DHSC has today announced the second wave of price concessions for December.

Pharmacies must continue to have the enhanced access to patient data that has been available to them during the Covid-19 pandemic, sector bodies have said.

Simon Dukes says he is hopeful the Covid-19 pandemic will help put an end to competition between pharmacies and GP surgeries over flu jabs.

The Department of Health and Social Care has today announced the final list of concessions for November.

The PSNC is seeking urgent clarity from NHS England & Improvement on the opening requirements for pharmacies over the Christmas period.

The DHSC has today announded the second wave of price concessions for November.

DHSC will advise which wholesalers have been allocated stock via the NHSBSA website.

The number of community pharmacies in England dropped to its lowest level in five years by the end of March 2020.

The majority of LPCs think their relationship with PSNC has improved over the past year despite the turmoil of Covid-19, according to poll.

The Department of Health and Social Care has today announced the first wave of concessions for November.

LPCs have expressed concerns to the PSNC about independents' place on the Wright review steering group.

Pfizer/BioNTech says its vaccine candidate is more than 90 per cent effective in preventing Covid-19.